These findings support the hypothesis that, in the context of MS, HLA DR and DQ alleles influence antigen presentation and immune response modulation by favoring the polarization of CD4+ T helper cells toward TH1 and TH17 responses [25]. The gene discussed is CD4; the disease is myeloid sarcoma.